FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Børge Nordestgaard

Research Profile

Geographic Areas

Denmark

Concepts & Ideas

Physiology

Disorders

Procedures

Case Control Studies

Living Beings

Heterozygote

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Louise S Hornstrup; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Shoaib Afzal; Stig E Bojesen; Børge G Nordestgaard
Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer.
Line Rode; Jørgen Vestbo; Maren Weischer; Stig E Bojesen; Børge G Nordestgaard
Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Børge Nordestgaard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Louise S Hornstrup; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(6):1441-7.
2013: Shoaib Afzal; Stig E Bojesen; Børge G Nordestgaard
Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer.
Clinical chemistry 2013;59(5):771-80.
2013: Line Rode; Jørgen Vestbo; Maren Weischer; Stig E Bojesen; Børge G Nordestgaard
Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals.
Thorax 2013;68(5):429-35.
2013: Maren Weischer; Richard M Cawthon; Jacob J Freiberg; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Stig E Bojesen
Short telomere length, cancer survival, and cancer risk in 47102 individuals.
Journal of the National Cancer Institute 2013;105(7):459-68.
2013: Birgitte F Sode; Kristine H Allin; Morten Dahl; Finn Gyntelberg; Børge G Nordestgaard
Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2013;185(5):E229-37.
2013: Pia R Kamstrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Journal of the American College of Cardiology 2013;61(11):1146-56.
2013: Christina Byrne; Daria Frestad; Andreas Fuchs; Lars Køber; J Tobias Kühl; Børge G Nordestgaard; Mette Zacho; Klaus Fuglsang Kofoed
Sex- and age-related differences of myocardial perfusion at rest assessed with multidetector computed tomography.
Journal of cardiovascular computed tomography 2013;7(2):94-101.
2013: P Brøndum-Jacobsen; Marianne Benn; Anne Tybjaerg-Hansen; Børge G Nordestgaard
25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants.
Journal of thrombosis and haemostasis : JTH 2013;11(3):423-31.
2013: Marie Helleberg; Gitte Kronborg; Carsten Schade Larsen; Børge G Nordestgaard; Shoaib Afzal; Jan Gerstoft; Court Pedersen; Gitte Pedersen; Niels Obel
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(5):727-34.
2013: Shoaib Afzal; Børge G Nordestgaard; Stig E Bojesen
Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
The Journal of investigative dermatology 2013;133(3):629-36.
2013: Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
Statin use and reduced cancer-related mortality.
The New England journal of medicine 2013;368(6):576-7.
2013: Shoaib Afzal; Stig E Bojesen; Børge G Nordestgaard
Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis.
Clinical chemistry 2013;59(2):381-91.
2013: Jolanta Klovaite; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Marianne Benn
Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis.
American journal of respiratory and critical care medicine 2013;187(3):286-93.
2013: Anette Varbo; Anne Tybjaerg-Hansen; Marianne Benn; Ruth Frikke-Schmidt; Anders B Jørgensen; Børge G Nordestgaard
Remnant cholesterol as a causal risk factor for ischemic heart disease.
Journal of the American College of Cardiology 2013;61(4):427-36.
2013: Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
[Cancer patients should not be treated with statins. Reply].
Ugeskrift for laeger 2013;175(1-2):76.
2013: Peter Brøndum-Jacobsen; Børge G Nordestgaard; Peter Schnohr; Marianne Benn
25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis.
Annals of neurology 2013;73(1):38-47.
2013: Mette Thomsen; Lester Kobzik; Børge G Nordestgaard; Morten Dahl
Genetic variation in the scavenger receptor MARCO and its association with chronic obstructive pulmonary disease and lung infection in 10,604 individuals.
Respiration; international review of thoracic diseases 2013;85(2):144-53.
2013: Camilla Nielsen; Børge G Nordestgaard; Henrik Birgens; Stig E Bojesen
Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.
British journal of haematology 2013;160(1):70-9.
2013: Stefan Stender; Marianne Benn; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.
Journal of hepatology 2013;58(1):126-33.
2013: S Stender; Ruth Frikke-Schmidt; P Grande; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Journal of internal medicine 2013;273(1):59-68.
2012: Jesper Schou; Anne Tybjaerg-Hansen; Holger J Møller; Børge G Nordestgaard; Ruth Frikke-Schmidt
ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population.
Diabetes care 2012;35(12):2600-6.
2012: Diljit Kaur-Knudsen; Børge G Nordestgaard; Stig E Bojesen
CHRNA3 genotype, nicotine dependence, lung function and disease in the general population.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;40(6):1538-44.
2012: Mette Thomsen; Jørgen Vestbo; Morten Dahl; Peter Lange; Børge G Nordestgaard
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2012;186(10):982-8.
2012: Trine Holm Johannsen; Børge G Nordestgaard; Jesper Schou; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Journal of the American College of Cardiology 2012;60(20):2041-8.
2012: Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
Statin use and reduced cancer-related mortality.
The New England journal of medicine 2012;367(19):1792-802.
2012: Peter Brøndum-Jacobsen; Gorm B Jensen; Marianne Benn; Børge G Nordestgaard
25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(11):2794-802.
2012: Marianne Benn; Anne Tybjaerg-Hansen; Gerald F Watts; Børge G Nordestgaard
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
The Journal of clinical endocrinology and metabolism 2012;97(11):3956-64.
2012: Nikolaj Eldrup; Charlotte Kragelund; Rolf Steffensen; Børge G Nordestgaard
Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2012;22(8):677-83.
2012: Niels Siggaard-Andersen; Jacob J Freiberg; Børge G Nordestgaard
Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids.
Danish medical journal 2012;59(7):A4470.
2012: Pia R Kamstrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(7):1732-41.
2012: Marianne Benn; Peer Grande; Gorm B Jensen; Mark I McCarthy; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Journal of the American College of Cardiology 2012;59(25):2356-65.
2012: Mette Thomsen; Anne Tybjaerg-Hansen; Morten Dahl; Børge G Nordestgaard
β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals.
The Journal of clinical endocrinology and metabolism 2012;97(6):E1074-9.
2012: David D Orsted; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard; Stig E Bojesen
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
European urology 2012;61(5):865-74.
2012: Samia Mora; Børge G Nordestgaard; S Matthijs Boekholdt; Robert J Glynn; John J P Kastelein; Paul M Ridker
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Journal of the American College of Cardiology 2012;59(17):1521-8.
2012: Maren Weischer; Anne Tybjaerg-Hansen; Stig E Bojesen; Richard M Cawthon; Jacob J Freiberg; Børge G Nordestgaard
Short telomere length, myocardial infarction, ischemic heart disease, and early death.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(3):822-9.
2012: M Thomsen; Anne Tybjaerg-Hansen; Børge G Nordestgaard; Amar A Sethi; Morten Dahl
β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;39(3):558-66.
2012: Jesper Schou; Efstathia Thymiakou; Ruth Frikke-Schmidt; Peer Grande; Gorm Jensen; Dimitris Kardassis; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(2):506-15.
2012: Christiane L Haase; Børge G Nordestgaard; Jesper Schou; Anne Tybjaerg-Hansen; Abbas Ali Qayyum; Ruth Frikke-Schmidt
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
The Journal of clinical endocrinology and metabolism 2012;97(2):E248-56.
2012: Magnus T Jensen; Jacob L Marott; Børge G Nordestgaard; Kristine H Allin; Gorm B Jensen
Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study.
European journal of preventive cardiology 2012;19(1):102-8.
2012: Christiane L Haase; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach.
PLoS genetics 2012;8(11):e1003063.
2012: Sune F Nielsen; Stig E Bojesen; Peter Schnohr; Børge G Nordestgaard
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study.
BMJ (Clinical research ed.) 2012;345():e5244.
2012: Marie Bækvad-Hansen; Børge G Nordestgaard; Morten Dahl
Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.
Respiratory research 2012;13():67.
2012: Børge G Nordestgaard; Tom M Palmer; Marianne Benn; George Davey Smith; Anne Tybjaerg-Hansen; Jeppe Zacho; Nick Timpson
The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach.
PLoS medicine 2012;9(5):e1001212.
2011: Stefan Stender; Aristomenis Anestis; Ruth Frikke-Schmidt; Dimitris Kardassis; Børge G Nordestgaard; Amar A Sethi; Anne Tybjaerg-Hansen
Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(12):2990-6.
2011: Sune F Nielsen; Henrik S Birgens; Stig E Bojesen; Børge G Nordestgaard
Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study.
Blood 2011;118(15):4062-9.
2011: Birgitte F Sode; Morten Dahl; Børge G Nordestgaard
Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals.
European heart journal 2011;32(19):2365-75.
2011: Christina Ellervik; Merete Frandsen; Thomas Mandrup-Poulsen; Henrik Ullits Andersen; Henrik Birgens; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Elevated transferrin saturation and risk of diabetes: three population-based studies.
Diabetes care 2011;34(10):2256-8.
2011: Louise S Hornstrup; Børge G Nordestgaard; Henrik Sillesen; Anne Tybjaerg-Hansen; Peer Grande; Christiane L Haase; Ruth Frikke-Schmidt
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Circulation. Cardiovascular genetics 2011;4(5):534-41.
2011: David D Ørsted; Stig E Bojesen; Sune F Nielsen; Børge G Nordestgaard
Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
European urology 2011;60(4):691-8.
2011: Julie Lee; Morten Dahl; Børge G Nordestgaard
Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(8):1673-82.
2011: Marianne S Nørskov; Henrik Sillesen; Ruth Frikke-Schmidt; Peer Grande; Steffen Loft; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses.
Circulation. Cardiovascular genetics 2011;4(4):418-28.
2011: C L Haase; A H Johnsen; D Kardassis; A K Kateifides; Lars Køber; L B Nielsen; Børge G Nordestgaard; C B Andersen; Ruth Frikke-Schmidt; P Grande; V I Zannis; Anne Tybjaerg-Hansen
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.
Journal of internal medicine 2011;270(2):136-46.
2011: M S Nørskov; Stig E Bojesen; Ruth Frikke-Schmidt; S Loft; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population.
The pharmacogenomics journal 2011;11(4):292-9.
2011: Diljit Kaur-Knudsen; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(21):2875-82.
2011: Kristine H Allin; Børge G Nordestgaard
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Critical reviews in clinical laboratory sciences 2011;48(4):155-70.
2011: Steen Stender; Børge G Nordestgaard
[Cholesterol--when is preventive treatment with statin indicated?].
Ugeskrift for laeger 2011;173(24):1747; author reply 1747.
2011: M John Chapman; Olivier S Descamps; Edward Fisher; Henry N Ginsberg; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Børge G Nordestgaard; Kausik K Ray; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjaerg-Hansen; Gerald F Watts; Pierre Amarenco; Felicita Andreotti; Jan Borén; Alberico L Catapano
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
European heart journal 2011;32(11):1345-61.
2011: Genovefa D Kolovou; Dimitri P Mikhailidis; Jan Kovar; Dennis Lairon; Børge G Nordestgaard; Teik Chye Ooi; Pablo Perez-Martinez; Helen Bilianou; Katherine K Anagnostopoulou; George Panotopoulos
Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.
Current vascular pharmacology 2011;9(3):258-70.
2011: Constantinos Mihas; Genovefa D Kolovou; Dimitri P Mikhailidis; Jan Kovar; Dennis Lairon; Børge G Nordestgaard; Teik Chye Ooi; Pablo Perez-Martinez; Helen Bilianou; Katherine K Anagnostopoulou; George Panotopoulos
Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis.
Current vascular pharmacology 2011;9(3):271-80.
2011: Børge G Nordestgaard; Jacob J Freiberg
Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol.
Current vascular pharmacology 2011;9(3):281-6.
2011: Genovefa D Kolovou; Dimitri P Mikhailidis; Børge G Nordestgaard; Helen Bilianou; George Panotopoulos
Definition of postprandial lipaemia.
Current vascular pharmacology 2011;9(3):292-301.
2011: Teik Chye Ooi; Børge G Nordestgaard
Methods to study postprandial lipemia.
Current vascular pharmacology 2011;9(3):302-8.
2011: Debbie A Lawlor; Roger M Harbord; Anne Tybjaerg-Hansen; Tom M Palmer; Jeppe Zacho; Marianne Benn; Nicholas J Timpson; George Davey Smith; Børge G Nordestgaard
Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53,221 adults.
Journal of internal medicine 2011;269(5):525-37.
2011: Stig E Bojesen; Julia S Johansen; Børge G Nordestgaard
Plasma YKL-40 levels in healthy subjects from the general population.
Clinica chimica acta; international journal of clinical chemistry 2011;412(9-10):709-12.
2011: Børge G Nordestgaard; Anne Tybjaerg-Hansen
Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk.
Current opinion in lipidology 2011;22(2):113-22.
2011: Anette Varbo; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Peter Schnohr; Gorm B Jensen; Marianne Benn
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population.
Annals of neurology 2011;69(4):628-34.
2011: Pia R Kamstrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
Scandinavian journal of clinical and laboratory investigation 2011;71(2):87-93.
2011: M Bækvad-Hansen; Børge G Nordestgaard; Morten Dahl
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;37(4):791-9.
2011: David Wormser; Stephen Kaptoge; Emanuele Di Angelantonio; Angela M Wood; Lisa Pennells; Alex Thompson; Nadeem Sarwar; Jorge R Kizer; Debbie A Lawlor; Børge G Nordestgaard; Paul Ridker; Veikko Salomaa; June Stevens; Mark Woodward; Naveed Sattar; Rory Collins; Simon G Thompson; Gary Whitlock; John Danesh
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
Lancet 2011;377(9771):1085-95.
2011: Marianne Benn; Anne Tybjaerg-Hansen; Stefan Stender; Ruth Frikke-Schmidt; Børge G Nordestgaard
Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.
Journal of the National Cancer Institute 2011;103(6):508-19.
2011: Christina Ellervik; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Total mortality by transferrin saturation levels: two general population studies and a metaanalysis.
Clinical chemistry 2011;57(3):459-66.
2011: Anne Langsted; Børge G Nordestgaard
Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study.
Clinical chemistry 2011;57(3):482-9.
2011: Camilla Nielsen; Henrik S Birgens; Børge G Nordestgaard; Lasse Kjaer; Stig E Bojesen
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population.
Haematologica 2011;96(3):450-3.
2011: Morten Dahl; Jørgen Vestbo; Jeppe Zacho; Peter Lange; Anne Tybjaerg-Hansen; Børge G Nordestgaard
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.
Thorax 2011;66(3):197-204.
2011: Stefan Stender; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population.
Hepatology (Baltimore, Md.) 2011;53(2):640-8.
2011: Holger Jon Møller; Ruth Frikke-Schmidt; Søren K Moestrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Clinical chemistry 2011;57(2):291-7.
2011: Anette Varbo; Marianne Benn; Anne Tybjaerg-Hansen; Peer Grande; Børge G Nordestgaard
TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(2):451-7.
2011: N J Timpson; Børge G Nordestgaard; Roger Harbord; J Zacho; T M Frayling; Anne Tybjaerg-Hansen; G Davey Smith
C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization.
International journal of obesity (2005) 2011;35(2):300-8.
2011: Jeppe Zacho; Shiva Yazdanyar; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls.
International journal of cancer. Journal international du cancer 2011;128(3):644-52.
2011: Mette Christoffersen; Ruth Frikke-Schmidt; Gorm B Jensen; Børge G Nordestgaard; Peter Schnohr; Anne Tybjaerg-Hansen
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.
BMJ (Clinical research ed.) 2011;343():d5497.
2011: Kristine H Allin; Henrik Flyger; Børge G Nordestgaard; Stig E Bojesen
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Breast cancer research : BCR 2011;13(3):R55.
2011: Kelley M Argraves; Jeremy L Barth; Patrick J Gazzolo; Katherine S Nicholas; Børge G Nordestgaard; Alan T Remaley; Amar A Sethi; Anne Tybjaerg-Hansen; Brent A Wilkerson; Sharon D Yeatts; Scott Argraves
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
Lipids in health and disease 2011;10():70.
2011: J Klovaite; Marianne Benn; S Yazdanyar; Børge G Nordestgaard
High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population.
Journal of thrombosis and haemostasis : JTH 2011;9(1):49-56.
2011: J Lee; Børge G Nordestgaard; Morten Dahl
EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;37(1):18-25.
2010: Børge G Nordestgaard; M John Chapman; Kausik Ray; Jan Borén; Felicita Andreotti; Gerald F Watts; Henry Ginsberg; Pierre Amarenco; Alberico Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjaerg-Hansen
Lipoprotein(a) as a cardiovascular risk factor: current status.
European heart journal 2010;31(23):2844-53.
2010: Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard
Common clinical practice versus new PRIM score in predicting coronary heart disease risk.
Atherosclerosis 2010;213(2):532-8.
2010: Alisa D Kjaergaard; Stig E Bojesen; Julia S Johansen; Børge G Nordestgaard
Elevated plasma YKL-40 levels and ischemic stroke in the general population.
Annals of neurology 2010;68(5):672-80.
2010: Julia S Johansen; Stig E Bojesen; Anne Tybjaerg-Hansen; Anne K Mylin; Paul A Price; Børge G Nordestgaard
Plasma YKL-40 and total and disease-specific mortality in the general population.
Clinical chemistry 2010;56(10):1580-91.
2010: Paul M Ridker; Jean G Macfadyen; Børge G Nordestgaard; Wolfgang Koenig; John J P Kastelein; Jacques Genest; Robert J Glynn
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk".
Circulation. Cardiovascular quality and outcomes 2010;3(5):447-52.
2010: Christina Ellervik; Anne Tybjaerg-Hansen; Merete Appleyard; Hans Ibsen; Børge G Nordestgaard
Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy.
Journal of internal medicine 2010;268(3):252-64.
2010: Sarah C W Marott; Børge G Nordestgaard; Jeppe Zacho; Jens Friberg; Gorm B Jensen; Anne Tybjaerg-Hansen; Marianne Benn
Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.
Journal of the American College of Cardiology 2010;56(10):789-95.
2010: Samia Mora; Pia R Kamstrup; Nader Rifai; Børge G Nordestgaard; Julie E Buring; Paul M Ridker
Lipoprotein(a) and risk of type 2 diabetes.
Clinical chemistry 2010;56(8):1252-60.
2010: Jeppe Zacho; Anne Tybjaerg-Hansen; Børge G Nordestgaard
C-reactive protein and risk of venous thromboembolism in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(8):1672-8.
2010: J J Freiberg; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Novel mutations in leukotriene C4 synthase and risk of cardiovascular disease based on genotypes from 50,000 individuals.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1694-701.
2010: Paul M Ridker; Jacques Genest; S Matthijs Boekholdt; Peter Libby; Antonio M Gotto; Børge G Nordestgaard; Samia Mora; Jean G MacFadyen; Robert J Glynn; John J P Kastelein
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.
Lancet 2010;376(9738):333-9.
2010: Amar A Sethi; Maureen Sampson; Russell Warnick; Nehemias Muniz; Boris Vaisman; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Alan T Remaley
High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.
Clinical chemistry 2010;56(7):1128-37.
2010: Jeppe Zacho; Anne Tybjaerg-Hansen; Børge G Nordestgaard
C-reactive protein and all-cause mortality--the Copenhagen City Heart Study.
European heart journal 2010;31(13):1624-32.
2010: Marianne Benn; Børge G Nordestgaard; Peer Grande; Peter Schnohr; Anne Tybjaerg-Hansen
PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Journal of the American College of Cardiology 2010;55(25):2833-42.
2010: Birgitte F Sode; Morten Dahl; Sune F Nielsen; Børge G Nordestgaard
Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.
American journal of respiratory and critical care medicine 2010;181(10):1085-92.
2010: Robert J Glynn; Wolfgang Koenig; Børge G Nordestgaard; James Shepherd; Paul M Ridker
Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.
Annals of internal medicine 2010;152(8):488-96, W174.
2010: Shiva Yazdanyar; Pia R Kamstrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Penetrance of NOD2/CARD15 genetic variants in the general population.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2010;182(7):661-5.
2010: Børge G Nordestgaard
Commentary: The Finnish success of cardiovascular risk factor reduction.
International journal of epidemiology 2010;39(2):518-9.
2010: Børge G Nordestgaard; Aram S Adourian; Jacob J Freiberg; Yu Guo; Pieter Muntendam; Erling Falk
Risk factors for near-term myocardial infarction in apparently healthy men and women.
Clinical chemistry 2010;56(4):559-67.
2010: Marie Baekvad-Hansen; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Morten Dahl
Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.
Respiratory medicine 2010;104(3):418-25.
2010: Kristine H Allin; Børge G Nordestgaard; Jeppe Zacho; Anne Tybjaerg-Hansen; Stig E Bojesen
C-reactive protein and the risk of cancer: a mendelian randomization study.
Journal of the National Cancer Institute 2010;102(3):202-6.
2010: Børge G Nordestgaard; Kimmo Kontula; Marianne Benn; Björn Dahlöf; Ulf de Faire; Jonathan M Edelman; Erik Eliasson; Frej Fyhrquist; Darcy A Hille; Hans Ibsen; Paulette A Lyle; Kåre Berg; Mia Sandberg; Amar A Sethi; Peggy H Wong; Ingrid Os
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
Pharmacogenetics and genomics 2010;20(2):77-85.
2010: Maren Weischer; Klaus Juul; Jeppe Zacho; Gorm B Jensen; Rolf Steffensen; Torben V Schroeder; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.
Atherosclerosis 2010;208(2):480-3.
2010: Thomas Benfield; Karen Ejrnaes; Klaus Juul; Christian Østergaard; Jannik Helweg-Larsen; Nina Weis; Lea Munthe-Fog; Gitte Kronborg; Marianne Ring Andersen; Anne Tybjaerg-Hansen; Børge G Nordestgaard; Peter Garred
Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study.
Critical care (London, England) 2010;14(2):R28.
2010: Julie Lee; Morten Dahl; Peer Grande; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.
Stroke; a journal of cerebral circulation 2010;41(1):27-33.
2010: Marie Baekvad-Hansen; Morten Dahl; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
American journal of respiratory and critical care medicine 2010;181(1):17-20.
2009: Kristine H Allin; Stig E Bojesen; Børge G Nordestgaard
[C-reactive protein, risk of and survival after cancer--secondary publication].
Ugeskrift for laeger 2009;171(48):3510-3.
2009: Paul M Ridker; Jean G MacFadyen; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Circulation. Cardiovascular quality and outcomes 2009;2(6):616-23.
2009: Ulrik Pedersen-Bjergaard; Søren L Nielsen; Kamran Akram; Hans Perrild; Børge G Nordestgaard; Hugh E Montgomery; Stig Pramming; Birger Thorsteinsson
Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study.
Pharmacogenetics and genomics 2009;19(11):864-8.
2009: Shiva Yazdanyar; Maren Weischer; Børge G Nordestgaard
Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis.
Clinical chemistry 2009;55(11):1950-7.
2009: Pia R Kamstrup; Børge G Nordestgaard
Lipoprotein(a) should be taken much more seriously.
Biomarkers in medicine 2009;3(5):439-41.
2009: Janne S Tolstrup; Morten Grønbaek; Børge G Nordestgaard
Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes.
Circulation. Cardiovascular genetics 2009;2(5):507-14.
2009: Børge G Nordestgaard
Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere.
Current opinion in lipidology 2009;20(5):393-401.
2009: D Kaur-Knudsen; Stig E Bojesen; Børge G Nordestgaard
Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
The pharmacogenomics journal 2009;9(5):327-32.
2009: Diljit Kaur-Knudsen; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Stig E Bojesen
CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals.
Pharmacogenetics and genomics 2009;19(9):685-94.
2009: Janne S Tolstrup; Morten Grønbaek; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population.
The American journal of gastroenterology 2009;104(9):2182-8.
2009: Julie Lee; Børge G Nordestgaard; Morten Dahl
Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity.
Respiratory medicine 2009;103(9):1286-92.
2009: Sarah Louise Dombernowsky; Maren Weischer; Jacob Johannes Freiberg; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(8):2339-42.
2009: Nick Timpson; Roger Harbord; George Davey Smith; Jeppe Zacho; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype.
Hypertension 2009;54(1):84-90.
2009: Jacob J Freiberg; Anne Tybjaerg-Hansen; Jan Skov Jensen; Børge G Nordestgaard
[Nonfasting triglycerides and risk of ischemic stroke--secondary publication].
Ugeskrift for laeger 2009;171(26):2188-91.
2009: Anne Langsted; Jacob J Freiberg; Børge G Nordestgaard
[Fasting and nonfasting lipids--secondary publication].
Ugeskrift for laeger 2009;171(26):2184-7.
2009: Pia R Kamstrup; Anne Tybjaerg-Hansen; Rolf Steffensen; Børge G Nordestgaard
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
JAMA : the journal of the American Medical Association 2009;301(22):2331-9.
2009: Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
[C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
Ugeskrift for laeger 2009;171(21):1751-5.
2009: Kristine H Allin; Stig E Bojesen; Børge G Nordestgaard
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2217-24.
2009: Børge G Nordestgaard; Marianne Benn
Fasting and nonfasting LDL cholesterol: to measure or calculate?
Clinical chemistry 2009;55(5):845-7.
2009: Gregory E Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease.
Genetic epidemiology 2009;33(4):317-24.
2009: Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
The New England journal of medicine 2009;360(18):1851-61.
2009: Paul M Ridker; Eleanor Danielson; Francisco Ah Fonseca; Jacques Genest; Antonio M Gotto; John Jp Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G Macfadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Lancet 2009;373(9670):1175-82.
2009: Jacob J Freiberg; Morten Dahl; Anne Tybjaerg-Hansen; Peer Grande; Børge G Nordestgaard
Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals.
Journal of molecular and cellular cardiology 2009;46(4):579-86.
2009: Trine Holm Johannsen; Pia R Kamstrup; Rolf V Andersen; Gorm B Jensen; Henrik Sillesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
The Journal of clinical endocrinology and metabolism 2009;94(4):1264-73.
2009: Børge G Nordestgaard; Linda Hilsted; Steen Stender
[Plasma lipids in non-fasting patients and signal values of laboratory results].
Ugeskrift for laeger 2009;171(13):1093.
2009: Julia S Johansen; Stig E Bojesen; Anne K Mylin; Ruth Frikke-Schmidt; Paul A Price; Børge G Nordestgaard
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):572-8.
2009: Morten Dahl; Børge G Nordestgaard
Markers of early disease and prognosis in COPD.
International journal of chronic obstructive pulmonary disease 2009;4():157-67.
2008: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
The New England journal of medicine 2008;359(21):2195-207.
2008: Jacob J Freiberg; Anne Tybjaerg-Hansen; Jan Skov Jensen; Børge G Nordestgaard
Nonfasting triglycerides and risk of ischemic stroke in the general population.
JAMA : the journal of the American Medical Association 2008;300(18):2142-52.
2008: Anne Langsted; Jacob J Freiberg; Børge G Nordestgaard
Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Circulation 2008;118(20):2047-56.
2008: Morten Dahl; Russell P Bowler; Klaus Juul; James D Crapo; Samuel Levy; Børge G Nordestgaard
Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.
American journal of respiratory and critical care medicine 2008;178(9):906-12.
2008: Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Genetically elevated C-reactive protein and ischemic vascular disease.
The New England journal of medicine 2008;359(18):1897-908.
2008: Daphne L van der A; Maroeska M Rovers; Diederick Grobbee; Joannes J M Marx; Jill Waalen; Christina Ellervik; Børge G Nordestgaard; John K Olynyk; Peter R Mills; James Shepherd; Bernard Grandchamp; Judith M Boer; Calogero Caruso; Marcello Arca; Beat J Meyer; Yvonne van der Schouw
Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects.
Circulation. Cardiovascular genetics 2008;1(1):43-50.
2008: Pia R Kamstrup; Anne Tybjaerg-Hansen; Rolf Steffensen; Børge G Nordestgaard
Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
The Journal of clinical endocrinology and metabolism 2008;93(10):3769-76.
2008: Janne S Tolstrup; Børge G Nordestgaard; Søren Rasmussen; Anne Tybjaerg-Hansen; Morten Grønbaek
[Genetic variations in alcohol dehydrogenase, drinking habits and alcoholism].
Ugeskrift for laeger 2008;170(35):2672-5.
2008: Maria C A Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Peer Grande; Peter Schnohr; Anne Tybjaerg-Hansen
Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.
Journal of the American College of Cardiology 2008;52(5):369-77.
2008: Sarah J Lewis; Debbie A Lawlor; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Shah Ebrahim; Jeppe Zacho; Andy Ness; Sam Leary; George Davey Smith
The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(1):35-40.
2008: Sarah Louise Dombernowsky; Maren Weischer; Kristine Højgaard Allin; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Risk of cancer by ATM missense mutations in the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3057-62.
2008: Ruth Frikke-Schmidt; Børge G Nordestgaard; Maria C A Stene; Amar A Sethi; Alan T Remaley; Peter Schnohr; Peer Grande; Anne Tybjaerg-Hansen
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
JAMA : the journal of the American Medical Association 2008;299(21):2524-32.
2008: Lasse S Ravn; Marianne Benn; Børge G Nordestgaard; Amar A Sethi; Birgit Agerholm-Larsen; Gorm B Jensen; Anne Tybjaerg-Hansen
Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Pharmacogenetics and genomics 2008;18(6):525-33.
2008: Marianne Benn; Marianne Schwartz; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population.
Circulation 2008;117(19):2492-501.
2008: Jacob J Freiberg; Anne Tybjaerg-Hansen; Henrik Sillesen; Gorm B Jensen; Børge G Nordestgaard
Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(5):990-6.
2008: Ulrik Pedersen-Bjergaard; Sukhbir S Dhamrait; Amar A Sethi; Erik Frandsen; Børge G Nordestgaard; Hugh E Montgomery; Stig Pramming; Philip Hougaard; Birger Thorsteinsson
Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
The American journal of medicine 2008;121(3):246.e1-8.
2008: Marianne Benn; Maria C A Stene; Børge G Nordestgaard; Gorm B Jensen; Rolf Steffensen; Anne Tybjaerg-Hansen
Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population.
The Journal of clinical endocrinology and metabolism 2008;93(3):1038-45.
2008: Maren Weischer; Stig E Bojesen; Christina Ellervik; Anne Tybjaerg-Hansen; Børge G Nordestgaard
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):542-8.
2008: Stig E Bojesen; Børge G Nordestgaard
The common germline Arg72Pro polymorphism of p53 and increased longevity in humans.
Cell cycle (Georgetown, Tex.) 2008;7(2):158-63.
2008: Pia R Kamstrup; Marianne Benn; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
Circulation 2008;117(2):176-84.
2008: Ruth Frikke-Schmidt; Børge G Nordestgaard; Gorm B Jensen; Rolf Steffensen; Anne Tybjaerg-Hansen
Genetic variation in ABCA1 predicts ischemic heart disease in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(1):180-6.
2007: Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
[Non-fasting triglycerides and risk of for myocardial infarction and death among women and men].
Ugeskrift for laeger 2007;169(45):3865-8.
2007: Christina Ellervik; Henrik Birgens; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.
Hepatology (Baltimore, Md.) 2007;46(4):1071-80.
2007: Marianne Benn; Børge G Nordestgaard; Jan Skov Jensen; Anne Tybjaerg-Hansen
Polymorphisms in apolipoprotein B and risk of ischemic stroke.
The Journal of clinical endocrinology and metabolism 2007;92(9):3611-7.
2007: Gregory E Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.
Genetic epidemiology 2007;31(6):515-27.
2007: Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
JAMA : the journal of the American Medical Association 2007;298(3):299-308.
2007: David Dynnes Ørsted; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population.
The Journal of experimental medicine 2007;204(6):1295-301.
2007: Christina Ellervik; Anne Tybjaerg-Hansen; Merete Appleyard; H Sillesen; G Boysen; Børge G Nordestgaard
Hereditary hemochromatosis genotypes and risk of ischemic stroke.
Neurology 2007;68(13):1025-31.
2007: Marianne Benn; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen
Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(3):661-70.
2007: Alisa D Kjaergaard; Christina Ellervik; Anne Tybjaerg-Hansen; Christen Kirk Axelsson; Marie-Louise Moes Grønholdt; Peer Grande; Gorm B Jensen; Børge G Nordestgaard
Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
Circulation 2007;115(7):861-71.
2007: Morten Dahl; Jørgen Vestbo; Peter Lange; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2007;175(3):250-5.
2007: Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Rolf Steffensen; Anne Tybjaerg-Hansen
Subsets of SNPs define rare genotype classes that predict ischemic heart disease.
Human genetics 2007;120(6):865-77.
2007: Charlotte L Tofteng; Pernille Bach-Mortensen; Stig E Bojesen; Anne Tybjaerg-Hansen; Lars Hyldstrup; Børge G Nordestgaard
Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.
Pharmacogenetics and genomics 2007;17(1):85-91.
2007: Maren Weischer; Stig E Bojesen; Anne Tybjaerg-Hansen; Christen Kirk Axelsson; Børge G Nordestgaard
Increased risk of breast cancer associated with CHEK2*1100delC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):57-63.
2006: Nikolaj Eldrup; Marie-Louise Moes Grønholdt; Henrik Sillesen; Børge G Nordestgaard
Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis.
Circulation 2006;114(17):1847-54.
2006: Maria C A Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Rolf Steffensen; Peter Schnohr; Anne Tybjaerg-Hansen
Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.
Atherosclerosis 2006;188(1):43-50.
2006: Maria C Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population.
Journal of lipid research 2006;47(5):944-52.
2006: Klaus Juul; Anne Tybjaerg-Hansen; Stefan Marklund; Peter Lange; Børge G Nordestgaard
Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2006;173(8):858-64.
2006: Hans H Wittrup; Rolf Vaern Andersen; Anne Tybjaerg-Hansen; Gorm B Jensen; Børge G Nordestgaard
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
The Journal of clinical endocrinology and metabolism 2006;91(4):1438-45.
2006: Nikolaj Eldrup; Henrik Sillesen; Eva Prescott; Børge G Nordestgaard
Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis.
European heart journal 2006;27(3):316-22.
2006: Jørgen Vestbo; Eva Prescott; Thomas Almdal; Morten Dahl; Børge G Nordestgaard; Teis Andersen; Thorkild I A Sørensen; Peter Lange
Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.
American journal of respiratory and critical care medicine 2006;173(1):79-83.
2005: Stig E Bojesen; S K Kjaer; Estrid V S Høgdall; B L Thomsen; C K Høgdall; Jan Blaakaer; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.
Endocrine-related cancer 2005;12(4):945-52.
2005: Thomas Benfield; Mortens Dahl; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study.
The Journal of infectious diseases 2005;192(10):1851-7.
2005: Ruth Frikke-Schmidt; Børge G Nordestgaard; Peter Schnohr; Rolf Steffensen; Anne Tybjaerg-Hansen
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population.
Journal of the American College of Cardiology 2005;46(8):1516-20.
2005: Marianne Benn; Børge G Nordestgaard; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Anne Tybjaerg-Hansen
Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population.
The Journal of clinical endocrinology and metabolism 2005;90(10):5797-803.
2005: Klaus Juul; Anne Tybjaerg-Hansen; Jann Mortensen; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Factor V leiden homozygosity, dyspnea, and reduced pulmonary function.
Archives of internal medicine 2005;165(17):2032-6.
2005: Amar A Sethi; Anne Tybjaerg-Hansen; Gorm B Jensen; Børge G Nordestgaard
164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study.
Pharmacogenetics and genomics 2005;15(9):633-45.
2005: Jan Skov Jensen; Bo Feldt-Rasmussen; Knut Borch-Johnsen; Kurt Svarre Jensen; Børge G Nordestgaard
Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension.
The Journal of clinical endocrinology and metabolism 2005;90(8):4441-5.
2005: Christina Ellervik; Anne Tybjaerg-Hansen; Peer Grande; Merete Appleyard; Børge G Nordestgaard
Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study.
Circulation 2005;112(2):185-93.
2005: Stig E Bojesen; Anne Tybjaerg-Hansen; Christen Kirk Axelsson; Børge G Nordestgaard
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.
British journal of cancer 2005;93(1):167-71.
2005: Marianne Benn; Børge G Nordestgaard; Jan Skov Jensen; Karin Nilausen; Hans Meinertz; Anne Tybjaerg-Hansen
Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor.
The Journal of biological chemistry 2005;280(22):21052-60.
2005: Isabel Gonçalves; Marie-Louise M Gronholdt; Ingrid Söderberg; Mikko P S Ares; Børge G Nordestgaard; Jacob F Bentzon; Gunilla Nordin Fredrikson; Jan Nilsson
Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1250-5.
2005: Jill Waalen; Børge G Nordestgaard; Ernest Beutler
The penetrance of hereditary hemochromatosis.
Best practice & research. Clinical haematology 2005;18(2):203-20.
2005: Klaus Juul; Anne Tybjaerg-Hansen; Stefan Marklund; Niels H H Heegaard; Rolf Steffensen; Henrik Sillesen; Gorm B Jensen; Børge G Nordestgaard
[Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication].
Ugeskrift for laeger 2005;167(7):767-70.
2005: Morten Dahl; Anne Tybjaerg-Hansen; Peter Lange; Børge G Nordestgaard
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
Respiratory research 2005;6():113.
2005: Anne Tybjaerg-Hansen; Henrik K Jensen; Marianne Benn; Rolf Steffensen; Gorm Jensen; Børge G Nordestgaard
Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(1):211-5.
2004: Morten Dahl; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
[Morbidity and mortality in persons with mannose-binding lectin deficiency. The Osterbro study].
Ugeskrift for laeger 2004;166(50):4606-9.
2004: Jeppe Frederiksen; Klaus Juul; Peer Grande; Gorm B Jensen; Torben V Schroeder; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.
Blood 2004;104(10):3046-51.
2004: Ruth Frikke-Schmidt; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.
The Journal of clinical investigation 2004;114(9):1343-53.
2004: Karen Kornerup; Børge G Nordestgaard; Trine Krogsgaard Jensen; Bo Feldt-Rasmussen; Jonas Peter Eiberg; Kurt Svarre Jensen; Jan Skov Jensen
Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis.
Cardiovascular research 2004;64(2):337-45.
2004: Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.
Human genetics 2004;115(4):331-45.
2004: Trine Krogsgaard Jensen; Børge G Nordestgaard; Bo Feldt-Rasmussen; Kurt Svarre Jensen; Jan Skov Jensen
Transvascular lipoprotein transport in patients with chronic renal disease.
Kidney international 2004;66(1):275-80.
2004: Jan Skov Jensen; Bo Feldt-Rasmussen; Kurt Svarre Jensen; Peter Clausen; Henrik Scharling; Børge G Nordestgaard
Transendothelial lipoprotein exchange and microalbuminuria.
Cardiovascular research 2004;63(1):149-54.
2004: Ruth Frikke-Schmidt; Børge G Nordestgaard; Peter Schnohr; Anne Tybjaerg-Hansen
Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study.
European heart journal 2004;25(11):943-51.
2004: Morten Dahl; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
A population-based study of morbidity and mortality in mannose-binding lectin deficiency.
The Journal of experimental medicine 2004;199(10):1391-9.
2004: Rolf Vaern Andersen; Anne Tybjaerg-Hansen; Merete Appleyard; Henrik Birgens; Børge G Nordestgaard
Hemochromatosis mutations in the general population: iron overload progression rate.
Blood 2004;103(8):2914-9.
2004: Klaus Juul; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.
Annals of internal medicine 2004;140(5):330-7.
2004: Amar A Sethi; Anne Tybjaerg-Hansen; Rolf Vaern Andersen; Børge G Nordestgaard
Nanogen microelectronic chip for large-scale genotyping.
Clinical chemistry 2004;50(2):443-6.
2004: Morten Dahl; Anne Tybjaerg-Hansen; Børge G Nordestgaard; Peter Lange; Jørgen Vestbo
Nose and blood pressure.
American journal of respiratory and critical care medicine 2004;169(2):318; author reply 319.
2004: Klaus Juul; Anne Tybjaerg-Hansen; Stefan Marklund; Niels H H Heegaard; Rolf Steffensen; Henrik Sillesen; Gorm Jensen; Børge G Nordestgaard
Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Circulation 2004;109(1):59-65.
2003: Morten Dahl; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(11):e55; author reply e55.
2003: Børge G Nordestgaard; Marie-Louise Moes Grønholdt; Henrik Sillesen
Echolucent rupture-prone plaques.
Current opinion in lipidology 2003;14(5):505-12.
2003: Karen Kornerup; Børge G Nordestgaard; Bo Feldt-Rasmussen; Knut Borch-Johnsen; Kurt Svarre Jensen; Jan Skov Jensen
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis.
Atherosclerosis 2003;170(1):163-8.
2003: Stig E Bojesen; Klaus Juul; Peter Schnohr; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
Journal of the American College of Cardiology 2003;42(4):661-7.
2003: Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Integrin beta3 Leu33Pro homozygosity and risk of cancer.
Journal of the National Cancer Institute 2003;95(15):1150-7.
2003: Amar A Sethi; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(7):1269-75.
2003: Rolf Vaern Andersen; Hans H Wittrup; Anne Tybjaerg-Hansen; Rolf Steffensen; Peter Schnohr; Børge G Nordestgaard
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
Journal of the American College of Cardiology 2003;41(11):1972-82.
2003: Amar A Sethi; Børge G Nordestgaard; Marie-Louise Moes Grønholdt; Rolf Steffensen; Gorm Jensen; Anne Tybjaerg-Hansen
Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease.
Hypertension 2003;41(6):1202-11.
2003: Peter Schnohr; Jan Skov Jensen; Henrik Scharling; Børge G Nordestgaard
[Individual and population based risk factors of ischemic heart diseases. A 21-year follow-up of 12,000 men and women from the Osterbro study].
Ugeskrift for laeger 2003;165(13):1353-8.
2003: Steen Christian Kofoed; Hans H Wittrup; Henrik Sillesen; Børge G Nordestgaard
Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study.
European heart journal 2003;24(6):567-76.
2003: Morten Dahl; Anne Tybjaerg-Hansen; Henrik Sillesen; Gorm Jensen; Rolf Steffensen; Børge G Nordestgaard
Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study.
Circulation 2003;107(5):747-52.
2002: Hans H Wittrup; Børge G Nordestgaard; Rolf Steffensen; Gorm Jensen; Anne Tybjaerg-Hansen
Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study.
Atherosclerosis 2002;165(1):119-26.
2002: Steen Christian Kofoed; Marie-Louise Moes Grønholdt; Jean Bismuth; Jens E Wilhjelm; Henrik Sillesen; Børge G Nordestgaard
Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women.
Journal of vascular surgery 2002;36(4):783-92.
2002: Lisbeth Enggaard Larsen; Christina Ellervik; Merete Appleyard; Børge G Nordestgaard; Henrik Birgens; Anne Tybjaerg-Hansen
[Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].
Ugeskrift for laeger 2002;164(39):4545-7.
2002: Karen Kornerup; Børge G Nordestgaard; Bo Feldt-Rasmussen; Knut Borch-Johnsen; Kurt Svarre Jensen; Jan Skov Jensen
Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(7):1168-74.
2002: Klaus Juul; Anne Tybjaerg-Hansen; Rolf Steffensen; Steen Kofoed; Gorm Jensen; Børge G Nordestgaard
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.
Blood 2002;100(1):3-10.
2002: Amar A Sethi; Anne Tybjaerg-Hansen; Marie-Louise Moes Grønhold; Rolf Steffensen; Peter Schnohr; Børge G Nordestgaard
[Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia].
Läkartidningen 2002;99(21):2392-3.
2002: Peter Schnohr; Jan Skov Jensen; Henrik Scharling; Børge G Nordestgaard
Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study.
European heart journal 2002;23(8):620-6.
2002: Klaus Juul; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Factor V Leiden: relation to fertility?
Lancet 2002;359(9309):894.
2002: Morten Dahl; Anne Tybjaerg-Hansen; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Annals of internal medicine 2002;136(4):270-9.
2002: Marie-Louise Moes Grønholdt; Børge G Nordestgaard; Jacob F Bentzon; Britt M Wiebe; Ji Zhou; Erling Falk; Henrik Sillesen
Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels.
Journal of vascular surgery 2002;35(1):137-45.
2001: Christina Ellervik; T Mandrup-Poulsen; Børge G Nordestgaard; Lisbeth Enggaard Larsen; Merete Appleyard; M Frandsen; P Petersen; P Schlichting; T Saermark; Anne Tybjaerg-Hansen; Henrik Birgens
Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
Lancet 2001;358(9291):1405-9.
2001: M Dahl; Anne Tybjaerg-Hansen; Jørgen Vestbo; Peter Lange; Børge G Nordestgaard
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2001;164(6):1008-11.
2001: Marie-Louise Moes Grønholdt; Børge G Nordestgaard; Torben V Schroeder; S Vorstrup; Henrik Sillesen
Ultrasonic echolucent carotid plaques predict future strokes.
Circulation 2001;104(1):68-73.
2001: Amar A Sethi; Anne Tybjaerg-Hansen; Marie-Louise Moes Grønholdt; Rolf Steffensen; Peter Schnohr; Børge G Nordestgaard
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.
Annals of internal medicine 2001;134(10):941-54.
2001: Marie-Louise Moes Grønholdt; Henrik Sillesen; Britt M Wiebe; Henning Laursen; Børge G Nordestgaard
Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2001;21(3):227-34.
2001: Amar A Sethi; Børge G Nordestgaard; B Agerholm-Larsen; E Frandsen; Gorm Jensen; Anne Tybjaerg-Hansen
Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study.
Hypertension 2001;37(3):875-81.
2001: Ruth Frikke-Schmidt; Børge G Nordestgaard; D Thudium; M L Moes Grønholdt; Anne Tybjaerg-Hansen
APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease.
Neurology 2001;56(2):194-200.
2001: Morten Dahl; Børge G Nordestgaard; P Lange; Jørgen Vestbo; Anne Tybjaerg-Hansen
Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
Clinical chemistry 2001;47(1):56-62.
2000: Ruth Frikke-Schmidt; Hans H Wittrup; Anne Tybjaerg-Hansen; Hans Meinertz; Peter Schnohr; Børge G Nordestgaard
Apolipoprotein E genotypes predict attendance rates at lipid clinic.
Atherosclerosis 2000;153(2):461-8.
2000: Ruth Frikke-Schmidt; Børge G Nordestgaard; B Agerholm-Larsen; Peter Schnohr; Anne Tybjaerg-Hansen
Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
Journal of lipid research 2000;41(11):1812-22.
2000: B Agerholm-Larsen; Anne Tybjaerg-Hansen; Peter Schnohr; Rolf Steffensen; Børge G Nordestgaard
Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.
Circulation 2000;102(18):2197-203.
2000: Hans H Wittrup; Børge G Nordestgaard; Henrik Sillesen; Peter Schnohr; Anne Tybjaerg-Hansen
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.
Circulation 2000;101(20):2393-7.
2000: B Agerholm-Larsen; Børge G Nordestgaard; Rolf Steffensen; Gorm Jensen; Anne Tybjaerg-Hansen
Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene.
Circulation 2000;101(16):1907-12.
2000: Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Rolf Steffensen; Gorm Jensen; Børge G Nordestgaard
Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study.
Journal of the American College of Cardiology 2000;35(5):1192-9.
2000: B Agerholm-Larsen; Børge G Nordestgaard; Anne Tybjaerg-Hansen
ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):484-92.
1999: B Agerholm-Larsen; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
ACE gene polymorphism explains 30-40% of variability in serum ACE activity in both women and men in the population at large: the Copenhagen City Heart Study.
Atherosclerosis 1999;147(2):425-7.
1999: Børge G Nordestgaard; Anne Tybjaerg-Hansen
Susceptibility mutations for ischemic heart disease.
Current atherosclerosis reports 1999;1(2):108-14.
1999: Henrik Orbaek Andersen; BF Hansen; P Holm; Steen Stender; Børge G Nordestgaard
Effect of cyclosporine on arterial balloon injury lesions in cholesterol-clamped rabbits: T lymphocyte-mediated immune responses not involved in balloon injury-induced neointimal proliferation.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1687-94.
1999: Hans H Wittrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.
Circulation 1999;99(22):2901-7.
1999: Hans H Wittrup; Anne Tybjaerg-Hansen; Rolf Steffensen; S S Deeb; J D Brunzell; Gorm Jensen; Børge G Nordestgaard
Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(6):1535-40.
1998: Hans H Wittrup; Anne Tybjaerg-Hansen; S Abildgaard; Rolf Steffensen; Peter Schnohr; Børge G Nordestgaard
[Frequent mutation doubles the risk of ischemic heart disease in women].
Ugeskrift for laeger 1998;160(27):4067-72.
1998: M Dahl; Anne Tybjaerg-Hansen; P Lange; Børge G Nordestgaard
DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.
Lancet 1998;351(9120):1911-3.
1998: Anne Tybjaerg-Hansen; R Steffensen; Hans Meinertz; Peter Schnohr; Børge G Nordestgaard
Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
The New England journal of medicine 1998;338(22):1577-84.
1998: M Dahl; Anne Tybjaerg-Hansen; Hans H Wittrup; P Lange; Børge G Nordestgaard
Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample.
Genomics 1998;50(1):89-96.
1998: Lars B Nielsen; K Juul; Børge G Nordestgaard
Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(4):641-9.
1998: Marie-Louise Moes Grønholdt; Børge G Nordestgaard; Britt M Wiebe; Jens E Wilhjelm; Henrik Sillesen
Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content.
Circulation 1998;97(1):34-40.
1997: Henrik Orbaek Andersen; P Holm; Steen Stender; BF Hansen; Børge G Nordestgaard
Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2515-23.
1997: Børge G Nordestgaard; S Abildgaard; Hans H Wittrup; Rolf Steffensen; Gorm Jensen; Anne Tybjaerg-Hansen
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Circulation 1997;96(6):1737-44.
1997: TG Nielsen; Børge G Nordestgaard; F von Jessen; J J Andreasen; A Wiik; N H Heegaard; Torben V Schroeder
Antibodies to cardiolipin may increase the risk of failure of peripheral vein bypasses.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 1997;14(3):177-84.
1997: B Agerholm-Larsen; Anne Tybjaerg-Hansen; Ruth Frikke-Schmidt; Marie-Louise Moes Grønholdt; G Jensen; Børge G Nordestgaard
ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease.
Annals of internal medicine 1997;127(5):346-55.
1997: P Holm; Steen Stender; Henrik Orbaek Andersen; BF Hansen; Børge G Nordestgaard
Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(8):1504-11.
1997: Børge G Nordestgaard; B Agerholm-Larsen; Alicja Mortensen; B Fischer Hansen; J Fischer Hansen; P Ibsen; K Kjeldsen
Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit.
Atherosclerosis 1997;132(1):119-22.
1997: Anne Tybjaerg-Hansen; B Agerholm-Larsen; S E Humphries; S Abildgaard; Peter Schnohr; Børge G Nordestgaard
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.
The Journal of clinical investigation 1997;99(12):3034-9.
1997: B Agerholm-Larsen; Børge G Nordestgaard; Rolf Steffensen; T I Sørensen; Gorm Jensen; Anne Tybjaerg-Hansen
ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study.
Circulation 1997;95(10):2358-67.
1997: Børge G Nordestgaard; B Agerholm-Larsen; Steen Stender
Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits.
Diabetologia 1997;40(5):512-20.
1997: Lars B Nielsen; M L Grønholdt; T V Schroeder; S Stender; Børge G Nordestgaard
In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):905-11.
1997: Hans H Wittrup; Anne Tybjaerg-Hansen; S Abildgaard; Rolf Steffensen; Peter Schnohr; Børge G Nordestgaard
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
The Journal of clinical investigation 1997;99(7):1606-13.
1996: Marie-Louise Moes Grønholdt; Børge G Nordestgaard; TG Nielsen; Henrik Sillesen
Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.
Stroke; a journal of cerebral circulation 1996;27(12):2166-72.
1996: Børge G Nordestgaard
The vascular endothelial barrier--selective retention of lipoproteins.
Current opinion in lipidology 1996;7(5):269-73.
1996: K Juul; Lars B Nielsen; K Munkholm; Steen Stender; Børge G Nordestgaard
Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo.
Circulation 1996;94(7):1698-704.
1996: Lars B Nielsen; Steen Stender; M Jauhiainen; Børge G Nordestgaard
Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.
The Journal of clinical investigation 1996;98(2):563-71.
1996: Lars B Nielsen; Steen Stender; Keld Kjeldsen; Børge G Nordestgaard
Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo.
Circulation research 1996;78(4):615-26.
1996: Børge G Nordestgaard; B Agerholm-Larsen; Hans H Wittrup; Anne Tybjaerg-Hansen
A prospective cardiovascular population study used in genetic epidemiology. The Copenhagen City Heart Study.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1996;226():65-71.
1995: Henrik Orbaek Andersen; P Holm; Steen Stender; B F Hansen; Keld Kjeldsen; Børge G Nordestgaard
Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts.
Transplantation 1995;60(7):631-8.
1995: Lars B Nielsen; P Leth-Espensen; Børge G Nordestgaard; E Foged; Keld Kjeldsen; Steen Stender
Replacement of dietary saturated fat with monounsaturated fat: effect on atherogenesis in cholesterol-fed rabbits clamped at the same plasma cholesterol level.
The British journal of nutrition 1995;74(4):509-21.
1995: Lars B Nielsen; Børge G Nordestgaard; Steen Stender; A Niendorf; Keld Kjeldsen
Transfer of lipoprotein(a) and LDL into aortic intima in normal and in cholesterol-fed rabbits.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1492-502.
1995: Henrik Orbaek Andersen; P Holm; Børge G Nordestgaard; B F Hansen; Keld Kjeldsen; L S Elinder; Steen Stender
Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
Journal of molecular and cellular cardiology 1995;27(8):1561-71.
1995: P Holm; Henrik Orbaek Andersen; Børge G Nordestgaard; B F Hansen; Keld Kjeldsen; Steen Stender
Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas.
Atherosclerosis 1995;115(2):191-200.
1995: Børge G Nordestgaard; R Wootton; B Lewis
Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(4):534-42.
1994: Børge G Nordestgaard; Lars B Nielsen
Atherosclerosis and arterial influx of lipoproteins.
Current opinion in lipidology 1994;5(4):252-7.
1994: Lars B Nielsen; Steen Stender; Keld Kjeldsen; Børge G Nordestgaard
Effect of angiotensin II and enalapril on transfer of low-density lipoprotein into aortic intima in rabbits.
Circulation research 1994;75(1):63-9.
1994: Henrik Orbaek Andersen; G Madsen; Børge G Nordestgaard; B F Hansen; Keld Kjeldsen; Steen Stender
Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(6):944-50.
1994: Henrik Orbaek Andersen; P Holm; Steen Stender; Børge G Nordestgaard; Keld Kjeldsen
Ischemic injury and experimental transplantation atherosclerosis.
Transplantation proceedings 1994;26(3):1812.
1994: Henrik Orbaek Andersen; G Madsen; Børge G Nordestgaard; Keld Kjeldsen; Steen Stender
Cyclosporin suppresses experimental transplant atherosclerosis.
Transplantation proceedings 1994;26(3):1738.
1993: Anne Tybjaerg-Hansen; Børge G Nordestgaard; Ulrik Gerdes; O Faergeman; S E Humphries
Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.
Atherosclerosis 1993;100(2):157-69.
1993: B A Larsen; Børge G Nordestgaard; Steen Stender; Keld Kjeldsen
Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels.
Atherosclerosis 1993;99(1):79-86.
1993: Lars B Nielsen; Børge G Nordestgaard; Steen Stender; Keld Kjeldsen
Aortic esterified cholesterol is not superior to total cholesterol as a measure of atherosclerosis severity in cholesterol-fed rabbits.
Atherosclerosis 1993;99(1):133-6.
1992: Lars B Nielsen; Børge G Nordestgaard; Steen Stender; Keld Kjeldsen
Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(12):1402-9.
1992: Børge G Nordestgaard; Anne Tybjaerg-Hansen
IDL, VLDL, chylomicrons and atherosclerosis.
European journal of epidemiology 1992;8 Suppl 1():92-8.
1992: Børge G Nordestgaard; Anne Tybjaerg-Hansen; B Lewis
Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(1):6-18.
1991: Anne Tybjaerg-Hansen; Børge G Nordestgaard; Ulrik Gerdes; S E Humphries
Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes.
Atherosclerosis 1991;89(1):69-81.
1991: M Shaikh; R Wootton; Børge G Nordestgaard; P Baskerville; J S Lumley; AE La Ville; J Quiney; B Lewis
Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):569-77.
1991: Børge G Nordestgaard; B Lewis
Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Atherosclerosis 1991;87(1):39-46.
1990: Børge G Nordestgaard; Erik Hjelms; Steen Stender; Keld Kjeldsen
Different efflux pathways for high and low density lipoproteins from porcine aortic intima.
Arteriosclerosis (Dallas, Tex.) 1990;10(3):477-85.
1989: T Ruys; I Sturgess; M Shaikh; Gerald F Watts; Børge G Nordestgaard; B Lewis
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
Lancet 1989;2(8672):1119-22.
1989: Erik Hjelms; Børge G Nordestgaard; Steen Stender; Keld Kjeldsen
A surgical model to study in vivo efflux of cholesterol from porcine aorta. Evidence for cholesteryl ester transfer through the aortic wall.
Atherosclerosis 1989;77(2-3):239-49.